REASEARCH PROJECT 2: Mycotoxin Biomarkers and Children's Health in Africa (Wild)

研究项目 2:非洲霉菌毒素生物标志物和儿童健康(野生)

基本信息

  • 批准号:
    8376301
  • 负责人:
  • 金额:
    $ 21.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-06-01 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

Child morbidity and mortality is high in sub-Saharan Africa with some 4.5 million deaths annually among children aged <5 years and 175 deaths per 1000 live births compared to 6 deaths per 1000 in industrialized nations. The majority of the childhood mortality and morbidity is due to infectious diseases, notably diarrhea, pneumonia and malaria. These problems are associated with poverty, including insufficient and poor quality food resulting in a high prevalence of malnutrition. Indeed under-nutrition and growth faltering has been identified as an underlying cause of around 50% of the deaths associated with infectious diseases in children in this region. In our previous work we found a strong association between aflatoxin biomarker levels and growth faltering in West African children; in addition, there was evidence of altered immunity in individuals with high biomarker levels. Dietary exposure to this mycotoxin may therefore make a significant contribution to childhood morbidity and mortality. The first goal of this project is to characterize the contribution of mycotoxin exposure early in life (pre- and post-natal) to growth faltering and health outcomes. We will test for an association between biomarkers of aflatoxin exposure and intestinal permeability as a first test of whether aflatoxin may affect growth via this mechanism. Maize is the main dietary staple for over 50% of the population in West Africa and is frequently co-contaminated with aflatoxins and another class of mycotoxins, the fumonisins. A second project goal is therefore to validate fumonisin exposure biomarkers to permit an evaluation of the combined effects of aflatoxins and fumonisins on child growth. Finally we will conduct postharvest intervention studies on maize using low technology approaches to assess their effectiveness in reducing human exposure to these environmental toxins, including via maize-based weaning foods that contribute much to the mycotoxin burden in young children. Collectively these studies will collaboratively link with biomarker research in Project 1 and lay the groundwork for application of targeted chemoprevention strategies described in Project 4.
撒哈拉以南非洲的儿童发病率和死亡率很高,#年每年约有450万人死亡 5岁儿童,每1000名活产儿中有175人死亡,而工业化国家每1000人中有6人死亡 国家。儿童死亡和发病率的大部分是由于传染病,特别是腹泻, 肺炎和疟疾。这些问题与贫穷有关,包括质量不足和质量差。 食物造成了营养不良的高度流行。事实上,营养不足和增长一直步履蹒跚 被确认为约50%与儿童传染病有关的死亡的根本原因 在这个地区。在我们之前的工作中,我们发现黄曲霉毒素生物标志物水平和 西非儿童发育迟缓;此外,有证据表明个人的免疫力发生了变化 生物标记物水平很高。因此,饮食中暴露于这种霉菌毒素可能会产生重大影响。 儿童发病率和死亡率。这个项目的第一个目标是描述 在生命早期(出生前和出生后)暴露真菌毒素对生长发育和健康结果的影响。我们将测试 黄曲霉毒素暴露的生物标记物与肠道通透性之间的关系作为是否 黄曲霉毒素可能通过这种机制影响生长。玉米是超过50%的人的主要主食 在西非的人口中,经常被黄曲霉毒素和另一类真菌毒素共同污染, 伏马尼辛。因此,第二个项目目标是验证伏马菌素暴露生物标记物,以允许 评价黄曲霉毒素和伏马菌素对儿童生长发育的联合作用。最后,我们将进行采后 玉米低技术干预效果评价研究 减少人类对这些环境毒素的暴露,包括通过以玉米为基础的断奶食品 对幼儿的霉菌毒素负担有很大影响。总体而言,这些研究将合作联系起来 在项目1中进行生物标记物研究,为靶向化学预防的应用奠定基础 项目4中描述的战略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTOPHER P WILD其他文献

CHRISTOPHER P WILD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTOPHER P WILD', 18)}}的其他基金

REASEARCH PROJECT 2: Mycotoxin Biomarkers and Children's Health in Africa (Wild)
研究项目 2:非洲霉菌毒素生物标志物和儿童健康(野生)
  • 批准号:
    7515860
  • 财政年份:
    2008
  • 资助金额:
    $ 21.19万
  • 项目类别:
REASEARCH PROJECT 2: Mycotoxin Biomarkers and Children's Health in Africa (Wild)
研究项目 2:非洲霉菌毒素生物标志物和儿童健康(野生)
  • 批准号:
    8278589
  • 财政年份:
  • 资助金额:
    $ 21.19万
  • 项目类别:
REASEARCH PROJECT 2: Mycotoxin Biomarkers and Children's Health in Africa (Wild)
研究项目 2:非洲霉菌毒素生物标志物和儿童健康(野生)
  • 批准号:
    7849772
  • 财政年份:
  • 资助金额:
    $ 21.19万
  • 项目类别:
REASEARCH PROJECT 2: Mycotoxin Biomarkers and Children's Health in Africa (Wild)
研究项目 2:非洲霉菌毒素生物标志物和儿童健康(野生)
  • 批准号:
    8078951
  • 财政年份:
  • 资助金额:
    $ 21.19万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了